Benzodiazepines for prolonged seizures.

INTRODUCTION Convulsive status epilepticus is a common emergency condition in paediatric practice. Classically, it is defi ned as continuous or recurrent seizure activity lasting for longer than 30 min in which the patient does not regain baseline mental status.1 Commonly, intervention is recommended after only 5 min of seizure activity2 as neuronal damage may begin to occur after this period, and the longer a seizure continues, the less likely it is to stop spontaneously.3 It seems likely, however, that mortality and morbidity after prolonged seizures should often be dependent upon underlying aetiology rather than duration of seizure activity.4 Repetitive serial seizures (ie, seizure clusters with return to baseline between events, but occurring frequently enough to be highly disruptive) and non-convulsive status epilepticus are also relatively common in children with epilepsy and are associated with signifi cant morbidity.5 Diazepam, lorazepam and midazolam, the drugs most widely used to stop prolonged seizures, are members of the benzodiazepine family, a class of psychoactive drugs with varying hypnotic, sedative, anxiolytic, anticonvulsant, muscle relaxant and amnesic properties.6 Differences in their affi nity for receptor subtypes account for different pharmacological effects, in combination with widely varying pharmacokinetic profi les. These pharmacokinetic differences often impose specifi c routes of administration and specifi c formulations for individual members of the benzodiazepine family. The aim of this review is to detail their clinical pharmacology as it relates to their use in the management of prolonged seizures in children.